Depletion of Tumor-Associated Macrophages Slows the Growth of Chemically Induced Mouse Lung Adenocarcinomas

Chronic inflammation is a risk factor for lung cancer, and low-dose aspirin intake reduces lung cancer risk. However, the roles that specific inflammatory cells and their products play in lung carcinogenesis have yet to be fully elucidated. In mice, alveolar macrophage numbers increase as lung tumors progress, and pulmonary macrophage programing changes within 2 weeks of carcinogen exposure. To examine how macrophages specifically affect lung tumor progression, they were depleted in mice bearing urethane-induced lung tumors using clodronate-encapsulated liposomes. Alveolar macrophage populations decreased to ≤50% of control levels after 4–6 weeks of liposomal clodronate treatment. Tumor burden decreased by 50% compared to vehicle treated mice, and tumor cell proliferation, as measured by Ki67 staining, was also attenuated. Pulmonary fluid levels of insulin-like growth factor-I, CXCL1, IL-6, and CCL2 diminished with clodronate liposome treatment. Tumor-associated macrophages expressed markers of both M1 and M2 programing in vehicle and clodronate liposome-treated mice. Mice lacking CCR2 (the receptor for macrophage chemotactic factor CCL2) had comparable numbers of alveolar macrophages and showed no difference in tumor growth rates when compared to similarly treated wild-type mice suggesting that while CCL2 may recruit macrophages to lung tumor microenvironments, redundant pathways can compensate when CCL2/CCR2 signaling is inactivated. Depletion of pulmonary macrophages rather than inhibition of their recruitment may be an advantageous strategy for attenuating lung cancer progression.

• Publication year

  2014

• Venue

  Frontiers in Immunology

• Publication date

  2014-11-25

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.3389/fimmu.2014.00587PMID 25505466PMCID 4243558
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials.

  2016influential reference
• Interleukin-6 signaling promotes alternative macrophage activation to limit obesity-associated insulin resistance and endotoxemia

  2014cited by this paper
• The Pro-Inflammatory Cytokine, Interleukin-6, Enhances the Polarization of Alternatively Activated Macrophages

  2014cited by this paper
• Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.

  2014cited by this paper
• Alveolar macrophages: plasticity in a tissue-specific context

  2014cited by this paper
• Tumour‐educated macrophages display a mixed polarisation and enhance pancreatic cancer cell invasion

  2014influential reference
• Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis

  2013cited by this paper
• Circulating interleukin‐6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy

  2013cited by this paper
• Expression of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in non-small cell lung cancer and its significance

  2013cited by this paper
• Vascular endothelial growth factor enhances macrophage clearance of apoptotic cells.

  2012cited by this paper
• 50 Years of Image Analysis

  2012cited by this paper
• NIH Image to ImageJ: 25 years of image analysis

  2012cited by this paper
• Modulation of Macrophage Efferocytosis in Inflammation

  2011cited by this paper
• A Critical Role for Macrophages in Promotion of Urethane-Induced Lung Carcinogenesis

  2011cited by this paper
• Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

  2011cited by this paper
• Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.

  2011cited by this paper
• Stimulation of neoplastic mouse lung cell proliferation by alveolar macrophage-derived, insulin-like growth factor-1 can be blocked by inhibiting MEK and PI3K activation

  2011influential reference
• Activation of PPARγ in Myeloid Cells Promotes Lung Cancer Progression and Metastasis

  2011cited by this paper
• Local Macrophage Proliferation, Rather than Recruitment from the Blood, Is a Signature of TH2 Inflammation

  2011cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• [Non small cell lung cancer].

  2010cited by this paper
• Tumorigenesis and Neoplastic Progression Tumor Progression Stage and Anatomical Site Regulate Tumor-Associated Macrophage and Bone Marrow-Derived Monocyte Polarization

  2010cited by this paper
• Dynamic, M2-Like Remodeling Phenotypes of CD11c+ Adipose Tissue Macrophages During High-Fat Diet–Induced Obesity in Mice

  2010cited by this paper
• Differential polarization of alveolar macrophages and bone marrow‐derived monocytes following chemically and pathogen‐induced chronic lung inflammation

  2010cited by this paper
• Liposomes for specific depletion of macrophages from organs and tissues.

  2010influential reference
• Lung tumor growth is stimulated in IFN-gamma-/- mice and inhibited in IL-4Ralpha-/- mice.

  2009cited by this paper
• Lung Tumor Growth is Stimulated in IFN-γ−/− Mice and Inhibited in IL-4Rα−/− Mice

  2009cited by this paper
• Lung environment determines unique phenotype of alveolar macrophages.

  2009cited by this paper
• Tumor necrosis factor-alpha from macrophages enhances LPS-induced clara cell expression of keratinocyte-derived chemokine.

  2008cited by this paper
• The Type 1 Insulin-Like Growth Factor Receptor Pathway

  2008cited by this paper
• Exploring the full spectrum of macrophage activation

  2008cited by this paper
• Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice

  2008influential reference
• Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene ExpressionMartinez FO, Gordon S, Locati M, et al (Univ of Milan, Italy; Univ of Oxford, England) J Immunol 177:7303–7311, 2006§

  2008cited by this paper
• The Insulin-Like Growth Factor Pathway in Lung Cancer

  2008cited by this paper
• Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages

  2008cited by this paper
• Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironment.

  2008cited by this paper
• Tumor signaling to the bone marrow changes the phenotype of monocytes and pulmonary macrophages during urethane-induced primary lung tumorigenesis in A/J mice.

  2007influential reference
• Inflammation and lung carcinogenesis: applying findings in prevention and treatment

  2007cited by this paper
• Clara cells impact the pulmonary innate immune response to LPS.

  2007cited by this paper
• Ovarian cancer cell–derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis

  2007cited by this paper
• Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis

  2007cited by this paper
• CC ligand 2 levels are increased in LPS-stimulated peripheral monocytes of patients with non-small cell lung cancer.

  2007cited by this paper
• Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation.

  2007cited by this paper
• Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression1

  2006cited by this paper
• Attenuation of the pulmonary inflammatory response following butylated hydroxytoluene treatment of cytosolic phospholipase A2 null mice.

  2006cited by this paper
• Interleukin (IL)‐4 and IL‐13 up‐regulate monocyte chemoattractant protein‐1 expression in human bronchial epithelial cells: involvement of p38 mitogen‐activated protein kinase, extracellular signal‐regulated kinase 1/2 and Janus kinase‐2 but not c‐Jun NH2‐terminal kinase 1/2 signalling pathways

  2006cited by this paper
• A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).

  2006cited by this paper
• Bradykinin phosphorylates mitogen-activated protein kinases in human lung fibroblasts through Epidermal Growth Factor Receptor transactivation

  2006cited by this paper
• Macrophages: obligate partners for tumor cell migration, invasion, and metastasis.

  2006cited by this paper
• Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach

  2006cited by this paper
• Argonaute—a database for gene regulation by mammalian microRNAs

  2005cited by this paper
• Human insulin-like growth factor-IA expression in transgenic mice promotes adenomatous hyperplasia but not pulmonary fibrosis.

  2005cited by this paper
• Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage.

  2004cited by this paper
• Classification of Proliferative Pulmonary Lesions of the Mouse

  2004cited by this paper
• Phospho-Akt Overexpression in Non–Small Cell Lung Cancer Confers Significant Stage-Independent Survival Disadvantage

  2004cited by this paper
• Life after corpse engulfment: phagocytosis of apoptotic cells leads to VEGF secretion and cell growth

  2004cited by this paper
• Inflammation and cancer

  2002cited by this paper
• Primary lung tumors in mice as an aid for understanding, preventing, and treating human adenocarcinoma of the lung.

  2001cited by this paper
• Regulation of lung epithelial cell morphology by cAMP-dependent protein kinase type I isozyme.

  2001cited by this paper
• The lung tumor promoter, butylated hydroxytoluene (BHT), causes chronic inflammation in promotion-sensitive BALB/cByJ mice but not in promotion-resistant CXB4 mice.

  2001cited by this paper
• Butylated hydroxytoluene (BHT) induction of pulmonary inflammation: a role in tumor promotion.

  2001cited by this paper
• Indomethacin reduces lung adenoma number in A/J mice.

  2001cited by this paper
• BUTYLATED HYDROXYTOLUENE (BHT) INDUCTION OF PULMONARY INFLAMMATION: A Role in Tumor Promotion

  2001cited by this paper
• Expression of growth hormone-releasing factor, growth hormone, insulin-like growth factor-1 and its binding proteins in human lung.

  2000cited by this paper
• Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes

  2000cited by this paper
• Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.

  2000cited by this paper
• Supernatants from quartz dust treated human macrophages stimulate cell proliferation of different human lung cells as well as collagen-synthesis of human diploid lung fibroblasts in vitro.

  1998cited by this paper
• Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell lung cancer.

  1998cited by this paper
• Mouse lung epithelial cell lines--tools for the study of differentiation and the neoplastic phenotype.

  1997cited by this paper
• Human recombinant monocyte chemotactic protein and other c‐c chemokines bind and induce directional migration of dendritic cells in vitro

  1996cited by this paper
• Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant.

  1994cited by this paper
• Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study

  1994influential reference
• The expression of insulin-like growth factors and their binding proteins in normal human lymphocytes.

  1993cited by this paper
• Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes.

  1991cited by this paper
• Smoking-attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States?

  1991cited by this paper
• Macrophage Subset Repopulation in the Spleen: Differential Kinetics After Liposome‐Mediated Elimination

  1989cited by this paper
• Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice

  1989cited by this paper
• Cancer: Principles and Practice of Oncology

  1983cited by this paper
• Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization.

  1982cited by this paper
• Cancer: Principles and Practice of Oncology

  1982cited by this paper
• [Inflammation and cancer].

  1974cited by this paper
• Edinburgh Research Explorer Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis Differential Ly-6C expression identi fi es the recruited macrophage phenotype, which orchestrates the regression of murine liver fi brosis

  year unknowncited by this paper

• Differential peritoneal resident macrophage depletion and omental milky spot disruption after high versus low clodronate‐loaded liposome dose treatment

  2026cites this paper
• Leveraging macrophage plasticity for precision-targeted tumor immunotherapy.

  2026cites this paper
• Fibrosis: cross-organ biology and pathways to development of innovative drugs

  2025cites this paper
• Harnessing the Power of Nanocarriers to Exploit the Tumor Microenvironment for Enhanced Cancer Therapy

  2025influential citation
• The role of SPP1+TAMs in cancer: Impact on patient prognosis and future therapeutic targets

  2025cites this paper
• Therapeutic targeting of tumour-associated macrophage receptors

  2025cites this paper
• The role of tumor-associated macrophages in lung cancer

  2025cites this paper
• Alveolar macrophages maintain tissue localization and gain enhanced anti-tumor activity in Lewis lung carcinoma-reprogrammed lung microenvironment

  2025cites this paper
• Immunotherapy combined with radiotherapy for advanced non-small cell lung cancer: Current status and challenge (Review)

  2025cites this paper
• Oridonin alleviates SiNPs-induced pulmonary fibrosis by inhibiting pyroptosis via IRE1α-XBP1s-NLRP3 pathway.

  2025cites this paper
• (-)-Guaiol Downregulates M2 Tumor-Associated Macrophage Polarization Through PPAR-γ Signaling to Suppress Lung Cancer

  2025cites this paper
• Role of the TLR signaling pathway in the pathogenesis of glioblastoma multiforme with an emphasis on immunotherapy

  2025cites this paper
• Antitumor immune response elicited by M2 TAM-specific DDS via C-type lectin CD209b using cholesteryl pullulan nanogel as a protein drug carrier.

  2025cites this paper
• IL4I1 in M2-like macrophage promotes glioma progression and is a promising target for immunotherapy

  2024cites this paper
• The roles of tissue resident macrophages in health and cancer

  2024cites this paper
• Hydrogel‐embedded precision‐cut lung slices support ex vivo culture of in vivo‐induced premalignant lung lesions

  2024cites this paper
• Non-Genotoxic and Environmentally Relevant Lower Molecular Weight Polycyclic Aromatic Hydrocarbons Significantly Increase Tumorigenicity of Benzo[a]pyrene in a Lung Two-Stage Mouse Model

  2024cites this paper
• Integrin β8 Facilitates Macrophage Infiltration and Polarization by Regulating CCL5 to Promote LUAD Progression

  2024cites this paper
• Targeting the lung tumour stroma: harnessing nanoparticles for effective therapeutic interventions

  2024cites this paper
• Lipid-based nanosystems: the next generation of cancer immune therapy

  2024influential citation
• The Role of TAMs in the Regulation of Tumor Cell Resistance to Chemotherapy.

  2024cites this paper
• Unraveling the tumor immune microenvironment of lung adenocarcinoma using single-cell RNA sequencing

  2024cites this paper
• Fibroblast and myofibroblast activation in normal tissue repair and fibrosis

  2024cites this paper
• Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy

  2024cites this paper
• Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors

  2024cites this paper
• Lactic acid in macrophage polarization: A factor in carcinogenesis and a promising target for cancer therapy.

  2024cites this paper
• Nanoparticle-Based Immunotherapy for Reversing T-Cell Exhaustion

  2024cites this paper
• Tissue-engineered models of lung cancer premalignancy

  2023cites this paper
• Hydrogel‐Embedded Precision‐Cut Lung Slices Model Lung Cancer Premalignancy Ex Vivo

  2023cites this paper
• Particulate matter-induced metabolic recoding of epigenetics in macrophages drives pathogenesis of chronic obstructive pulmonary disease.

  2023cites this paper
• MicroRNA-155 and cancer metastasis: Regulation of invasion, migration, and epithelial-to-mesenchymal transition.

  2023cites this paper
• Lipid-based nanoparticles for cancer immunotherapy

  2023cites this paper
• A new approach to overcoming resistance to immunotherapy: nanotechnology

  2023cites this paper
• Modeling Mechanical Activation of Macrophages During Pulmonary Fibrogenesis for Targeted Anti-Fibrosis Therapy

  2023cites this paper
• Emerging agents for the treatment of advanced or metastatic NSCLC without actionable genomic alterations with progression on first-line therapy

  2023cites this paper
• Precision cut lung slices as a preclinical model for non-small cell lung cancer chemoprevention.

  2023cites this paper
• Loss of Frizzled 9 in Lung Cells Alters Epithelial Phenotype and Promotes Premalignant Lesion Development

  2022cites this paper
• Immunometabolic attributes and mitochondria-associated signaling of Tumor-Associated Macrophages in tumor microenvironment modulate cancer progression.

  2022cites this paper
• Mannosylated engineered trichosanthin-legumain protein vaccine hydrogel for breast cancer immunotherapy.

  2022cites this paper
• Lcn2 mediates adipocyte-muscle-tumor communication and hypothermia in pancreatic cancer cachexia

  2022cites this paper
• Clinical relevance and therapeutic aspects of professional antigen-presenting cells in lung cancer

  2022cites this paper
• Telomere-Associated Changes in Nuclear Architecture of Cancer-Associated Macrophage-like Cells in Liquid Biopsies from Melanoma Patients

  2022cites this paper
• Cancer Resistance to Immunotherapy: Molecular Mechanisms and Tackling Strategies

  2022cites this paper
• Myeloid-cell-specific role of Gasdermin D in promoting lung cancer progression in mice

  2022cites this paper
• New Immuno-oncology Targets and Resistance Mechanisms

  2022cites this paper
• Resolvin E1 Reduces Tumor Growth in a Xenograft Model of Lung Cancer.

  2022cites this paper
• Developing a Copper(II) Agent Based on His-146 and His-242 Residues of Human Serum Albumin Nanoparticles: Integration To Overcome Cisplatin Resistance and Inhibit the Metastasis of Nonsmall Cell Lung Cancer.

  2022cites this paper
• Iloprost requires the Frizzled-9 receptor to prevent lung cancer

  2022cites this paper
• Self-assembled polysaccharide nanogel delivery system for overcoming tumor immune resistance.

  2022cites this paper
• Nonclinical Characterization of Bexmarilimab, a Clever-1–Targeting Antibody for Supporting Immune Defense Against Cancers

  2022cites this paper
• Heat shock protein-70 expression in CSCs tumor-associated macrophages induced by Typhonium flagelliforme tuber extract

  2022cites this paper
• Harnessing anti‐tumor and tumor‐tropism functions of macrophages via nanotechnology for tumor immunotherapy

  2022cites this paper
• Macrophage-Targeted Chemotherapy for Respiratory Diseases Other Than Tuberculosis

  2022cites this paper
• Understanding Macrophage-Associated Diseases and Applications of Nanodrug Delivery Systems

  2022cites this paper
• Transcriptional and Microenvironmental Landscape of Macrophage Transition in Cancer: A Boolean Analysis

  2021cites this paper
• Macrophages in multiple myeloma: key roles and therapeutic strategies

  2021cites this paper
• Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?

  2021cites this paper
• Tumor microenvironment and nanotherapeutics: intruding the tumor fort.

  2021cites this paper
• Tumor-Associated Macrophages in Bladder Cancer: Biological Role, Impact on Therapeutic Response and Perspectives for Immunotherapy

  2021cites this paper
• Intranasal Iloprost Prevents Tumors in a Murine Lung Carcinogenesis Model

  2021cites this paper
• Macrophages in multiple myeloma: key roles and therapeutic strategies

  2021cites this paper
• Tumor-Associated Macrophages and Their Functional Transformation in the Hypoxic Tumor Microenvironment

  2021cites this paper
• Modulating tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors: A TAM-pting approach.

  2021cites this paper
• Nanobiotechnology and Immunotherapy: Two Powerful and Cooperative Allies against Cancer

  2021cites this paper
• Treatment Observed by Pulmonary Functional Hyperpolarized Xe MRI in Mice

  2021cites this paper
• The inflammatory speech of fibroblasts

  2021cites this paper
• Tissue-Resident and Recruited Macrophages in Primary Tumor and Metastatic Microenvironments: Potential Targets in Cancer Therapy

  2021cites this paper
• Tumor-associated macrophages secret exosomal miR-155 and miR-196a-5p to promote metastasis of non-small-cell lung cancer

  2021cites this paper
• Application of nanotechnology in drug delivery systems for respiratory diseases

  2021cites this paper
• Inflammation during Lung Cancer Progression and Ethyl Pyruvate Treatment Observed by Pulmonary Functional Hyperpolarized 129Xe MRI in Mice

  2021cites this paper
• Two-stage 3-methylcholanthrene and butylated hydroxytoluene-induced lung carcinogenesis in mice.

  2021cites this paper
• Cancer metastasis as a non-healing wound

  2021cites this paper
• Function of Macrophages in Disease: Current Understanding on Molecular Mechanisms

  2021cites this paper
• Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophages.

  2021cites this paper
• Addressing resistance to immune checkpoint inhibitor therapy - an urgent unmet need.

  2021cites this paper
• Research trends in pharmacological modulation of tumor‐associated macrophages

  2021cites this paper
• BMI1 regulates multiple myeloma-associated macrophage’s pro-myeloma functions

  2021cites this paper
• Overexpression of PRDX4 Modulates Tumor Microenvironment and Promotes Urethane-Induced Lung Tumorigenesis

  2020cites this paper
• Determining macrophage versus neutrophil contributions to innate immunity using larval zebrafish

  2020cites this paper
• Targeting alveolar macrophages shows better treatment response than deletion of interstitial macrophages in EGFR mutant lung adenocarcinoma

  2020cites this paper
• Pharmacological targets of metabolism in disease: Opportunities from macrophages.

  2020cites this paper
• Mechanisms of Resistance to Checkpoint Blockade Therapy.

  2020cites this paper
• Harnessing Therapeutic IgE Antibodies to Re-educate Macrophages against Cancer.

  2020cites this paper
• The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy

  2020cites this paper
• Mesothelial cells regulate immune responses in health and disease: role for immunotherapy in malignant mesothelioma.

  2020cites this paper
• Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blocker

  2020cites this paper
• Mechanisms of resistance to immune checkpoint inhibitors and strategies to reverse drug resistance in lung cancer

  2020cites this paper
• Adjuvant Antitumor Immunity Contributes to the Overall Antitumor Effect of Pegylated Liposomal Doxorubicin (Doxil®) in C26 Tumor-Bearing Immunocompetent Mice

  2020cites this paper
• Targeted Delivery of Dasatinib to Deplete Tumor-Associated Macrophages by Mannosylated Mixed Micelles for Tumor Immunotherapy.

  2020cites this paper
• The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy

  2020cites this paper
• Macrophages Mediate the Antitumor Effects of the Oncolytic Virus HSV1716 in Mammary Tumors

  2020cites this paper
• Tumor-Associated Macrophages Secret Exosomal miR-155 to Promote Metastasis of Non-Small-Cell Lung Cancer

  2020cites this paper
• Clodronate-Liposome Mediated Macrophage Depletion Abrogates Multiple Myeloma Tumor Establishment In Vivo

  2019cites this paper
• Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?

  2019cites this paper
• Scavenging reactive oxygen species selectively inhibits M2 macrophage polarization and their pro-tumorigenic function in part, via Stat3 suppression.

  2019cites this paper
• Drug delivery to macrophages: A review of targeting drugs and drug carriers to macrophages for inflammatory diseases.

  2019cites this paper
• Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity

  2019cites this paper
• 小细胞肺癌诊疗新进展

  2019cites this paper
• Poly(I:C) stimulation is superior than Imiquimod to induce the antitumoral functional profile of tumor‐conditioned macrophages

  2019cites this paper
• Innate and Adaptive Immune Responses to Cancer

  2019cites this paper